Endocervical glandular lesions exhibiting gastric differentiation: An emerging spectrum of benign, premalignant, and malignant lesions

Advances in Anatomic Pathology

Volumn 20, Issue 4, 2013, Pages 227-237

  Mikami, Yoshiki ^a   McCluggage, W Glenn ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Adenocarcinoma; Cervix; Gastric type; Lobular endocervical glandular hyperplasia

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; MUCIN 6; PROTEIN P53; WART VIRUS VACCINE;

CONDYLOMA ACUMINATUM; GASTRIC TYPE ADENOCARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA; MINIMAL DEVIATION ADENOCARCINOMA; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; VACCINATION;

ADENOCARCINOMA; BIOPSY; CARCINOMA IN SITU; CELL DIFFERENTIATION; ENDOMETRIAL HYPERPLASIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MUCIN-6; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84880162395     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e31829c2d66     Document Type: Review

References (71)

1. Houghton O, Jamison J, Wilson R, et al. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Histopathology. 2010;57: 342-350.
2. Park KJ, Kiyokawa T, Soslow RA, et al. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol. 2011;35:633-646.
3. Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 2000;157:1055-1062.
4. Kenny SL, McBride HA, Jamison J, et al. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPVnegative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-beta. Am J Surg Pathol. 2012; 36:799-807.
5. Mikami Y, Hata S, Melamed J, et al. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology. 2001;39:364-372. (Pubitemid 32990087)
6. Mikami Y, Kiyokawa T, Hata S, et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod Pathol. 2004;17:962-972. (Pubitemid 38993781)
7. Kondo T, Hashi A, Murata SI, et al. Gastric mucin is expressed in a subset of endocervical tunnel clusters: type A tunnel clusters of gastric phenotype. Histopathology. 2007;50: 843-850. (Pubitemid 46850079)
8. Hayashi I, Tsuda H, Shimoda T. Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix. Am J Surg Pathol. 2000;24:559-562. (Pubitemid 30180749)
9. Ishii K, Hosaka N, Toki T, et al. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch. 1998; 432:315-322. (Pubitemid 28171993)
10. Mikami Y, Hata S, Fujiwara K, et al. Florid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia: worrisome benign mimic of "adenoma malignum". Gynecol Oncol. 1999;74:504-511. (Pubitemid 29439901)
11. Nucci MR, Clement PB, Young RH. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol. 1999;23:886-891. (Pubitemid 29360105)
12. Mikami Y, Manabe T. Lobular endocervical glandular hyperplasia represents pyloric gland metaplasia? Am J Surg Pathol. 2000;24:323-324, author reply 325-326.
13. Nara M, Hashi A, Murata S, et al. Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection. Gynecol Oncol. 2007;106:289-298. (Pubitemid 47087929)
14. Takeuchi K, Tsujino T, Sugimoto M, et al. Endocervical adenocarcinoma associated with lobular endocervical glandular hyperplasia showing rapid reaccumulation of hydrometra. Int J Gynecol Cancer. 2008;18:1285-1288.
15. Ohta Y, Suzuki T, Hamatani S, et al. Lobular endocervical glandular hyperplasia might become a precursor of adenocarcinoma with pyloric gland features. Pathol Res Pract. 2008;204: 683-687.
16. Nishio S, Tsuda H, Fujiyoshi N, et al. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia. Pathol Res Pract. 2009;205:331-337.
17. Tsuji T, Togami S, Nomoto M, et al. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia. Histopathology. 2011;59:55-62.
18. Fukushima M, Shimano S, Yamakawa Y, et al. The detection of human papillomavirus (HPV) in a case of minimal deviation adenocarcinoma of the uterine cervix (adenoma malignum) using in situ hybridization. Jpn J Clin Oncol. 1990;20:407-412.
19. Ferguson AW, Svoboda-Newman SM, Frank TS. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol. 1998;11:11-18. (Pubitemid 28177356)
20. Toki T, Zhai YL, Park JS, et al. Infrequent occurrence of highrisk human papillomavirus and of p53 mutation in minimal deviation adenocarcinoma of the cervix. Int J Gynecol Pathol. 1999;18:215-219. (Pubitemid 29306977)
21. Xu JY, Hashi A, Kondo T, et al. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int J Gynecol Pathol. 2005;24:296-302. (Pubitemid 40885086)
22. Kojima A, Mikami Y, Sudo T, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol. 2007;31: 664-672. (Pubitemid 46684204)
23. Mikami Y. Reply. Gynecol Oncol. 2000;77:342-343.
24. Kato N, Sugawara M, Maeda K, et al. Pyloric gland metaplasia/ differentiation in multiple organ systems in a patient with Peutz-Jegher's syndrome. Pathol Int. 2011;61:369-372.
25. ItoM, Minamiguchi S, Mikami Y, et al. Peutz-Jeghers syndromeassociated atypical mucinous proliferation of the uterine cervix: a case of minimal deviation adenocarcinoma ('adenoma malignum') in situ. Pathol Res Pract. 2012;208:623-627.
26. Hirasawa A, Akahane T, Tsuruta T, et al. Lobular endocervical glandular hyperplasia and peritoneal pigmentation associated with Peutz-Jeghers syndrome due to a germline mutation of STK11. Ann Oncol. 2012;23:2990-2992.
27. Hahn HS, Maeng LS, Ro DY, et al. Lobular endocervical glandular hyperplasia in a woman with Peutz-Jeghers syndrome: a case report. Eur J Obstet Gynecol Reprod Biol. 2012;160:117-118.
28. Sasajima Y, Mikami Y, Kaku T, et al. Gross features of lobular endocervical glandular hyperplasia in comparison with minimal-deviation adenocarcinoma and stage Ib endocervicaltype mucinous adenocarcinoma of the uterine cervix. Histopathology. 2008;53:487-490.
29. Yoden E, Mikami Y, Fujiwara K, et al. Florid endocervical glandular hyperplasia with pyloric gland metaplasia: a radiologic pitfall. J Comput Assist Tomogr. 2001;25:94-97. (Pubitemid 32099215)
30. Takatsu A, Shiozawa T, Miyamoto T, et al. Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings. Int J Gynecol Cancer. 2011;21: 1287-1296.
31. Zavada J, Zavadova Z, Pastorekova S, et al. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer. 1993;54:268-274. (Pubitemid 23154893)
32. Mikami Y, Minamiguchi S, Teramoto N, et al. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix. Pathol Res Pract. 2013;209:173-178.
33. Liao SY, Rodgers WH, Kauderer J, et al. Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study. Br J Cancer. 2011;104:353-360.
34. Liao SY, Rodgers WH, Kauderer J, et al. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States. Int J Cancer. 2009;125:2434-2440.
35. Hata S, Mikami Y, Manabe T. Diagnostic significance of endocervical glandular cells with "golden-yellow" mucin on pap smear. Diagn Cytopathol. 2002;27:80-84. (Pubitemid 34832877)
36. Ishii K, Katsuyama T, Ota H, et al. Cytologic and cytochemical features of adenoma malignum of the uterine cervix. Cancer. 1999;87:245-253. (Pubitemid 29503477)
37. Takeuchi K, Tsujino T, Yasumizu R, et al. Possible relationship between chronic inflammation and pyloric metaplasia in a patient with lobular endocervical glandular hyperplasia. Eur J Gynaecol Oncol. 2009;30:707-710.
38. Fetissof F, Berger G, Dubois MP, et al. Female genital tract and Peutz-Jeghers syndrome: an immunohistochemical study. Int J Gynecol Pathol. 1985;4:219-229. (Pubitemid 16214525)
39. Fetissof F, Heitzman A, Machet MC, et al. Unusual endocervical lesions with endocrine cells. Pathol Res Pract. 1993;189:928-939. (Pubitemid 23308016)
40. Tsuda H, Mikami Y, Kaku T, et al. Interobserver variation in the diagnosis of adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. Pathol Int. 2003; 53:440-449. (Pubitemid 37000045)
41. Tsuda H, Mikami Y, Kaku T, et al. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria. Pathol Int. 2005;55:412-418. (Pubitemid 41097805)
42. Choi CG, Kim SH, Kim JS, et al. Adenoma malignum of uterine cervix in Peutz-Jeghers syndrome: CT and US features. J Comput Assist Tomogr. 1993;17:819-821.
43. Tsuruchi N, Tsukamoto N, Kaku T, et al. Adenoma malignum of the uterine cervix detected by imaging methods in a patient with Peutz-Jeghers syndrome. Gynecol Oncol. 1994;54:232-236. (Pubitemid 24256477)
44. Doi T, Yamashita Y, Yasunaga T, et al. Adenoma malignum: MR imaging and pathologic study. Radiology. 1997;204:39-42. (Pubitemid 27281706)
45. Yamashita Y, Takahashi M, Katabuchi H, et al. Adenoma malignum: MR appearances mimicking nabothian cysts. Am J Roentgenol. 1994;162:649-650. (Pubitemid 24093571)
46. Gilks CB, Young RH, Aguirre P, et al. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol. 1989;13:717-729. (Pubitemid 19201942)
47. Cina SJ, Richardson MS, Austin RM, et al. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol. 1997;10:176-180. (Pubitemid 27130454)
48. Ichimura T, Koizumi T, Tateiwa H, et al. Immunohistochemical expression of gastric mucin and p53 in minimal deviation adenocarcinoma of the uterine cervix. Int J Gynecol Pathol. 2001;20:220-226. (Pubitemid 32578106)
49. Mikami Y, Kiyokawa T, Moriya T, et al. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining. Histopathology. 2005;46:130-136. (Pubitemid 40293010)
50. Zhao S, Hayasaka T, Osakabe M, et al. Mucin expression in nonneoplastic and neoplastic glandular epithelia of the uterine cervix. Int J Gynecol Pathol. 2003;22:393-397. (Pubitemid 37152991)
51. Kawauchi S, Kusuda T, Liu XP, et al. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study. Am J Surg Pathol. 2008;32:1807-1815.
52. Wells M, Ostor AG, Crum CP, et al. Epithelial tumours. WHO classification of tumours. In: Tavassoli FA, Devilee P, eds. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003:262-279.
53. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology. 2002;41:185-207. (Pubitemid 35013941)
54. Kusanagi Y, Kojima A, Mikami Y, et al. Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype. Am J Pathol. 2010;177:2169-2175.
55. Kawakami F, Mikami Y, Kojima A, et al. Diagnostic reproducibility in gastric-type mucinous adenocarcinoma of the uterine cervix: validation of novel diagnostic criteria. Histopathology. 2010;56:551-553.
56. McCluggage WG, Harley I, Houghton JP, et al. Composite cervical adenocarcinoma composed of adenoma malignum and gastric type adenocarcinoma (dedifferentiated adenoma malignum) in a patient with Peutz Jeghers syndrome. J Clin Pathol. 2010;63:935-941.
57. Kuragaki C, Enomoto T, Ueno Y, et al. Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix. Lab Invest. 2003;83:35-45. (Pubitemid 36157292)
58. Lee JY, Dong SM, Kim HS, et al. A distinct region of chromosome 19p13.3 associated with the sporadic form of adenoma malignum of the uterine cervix. Cancer Res. 1998; 58:1140-1143. (Pubitemid 28183200)
59. Miyai K, Furugen Y, Matsumoto T, et al. Loss of heterozygosity analysis in uterine cervical adenocarcinoma. Gynecol Oncol. 2004;94:115-120. (Pubitemid 38950506)
60. Connolly DC, Katabuchi H, Cliby WA, et al. Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome. Am J Pathol. 2000;156:339-345. (Pubitemid 30644468)
61. Tsuda H, Takarabe T, Okada S, et al. Different pattern of loss of heterozygosity among endocervical-type adenocarcinoma, endometrioid-type adenocarcinoma and adenoma malignum of the uterine cervix. Int J Cancer. 2002;98:713-717. (Pubitemid 34225621)
62. Nakayama J, Yeh JC, Misra AK, et al. Expression cloning of a human alpha1, 4-N-acetylglucosaminyltransferase that forms GlcNAcalpha1->4Galbeta- >R, a glycan specifically expressed in the gastric gland mucous cell-type mucin. Proc Natl Acad Sci USA. 1999;96:8991-8996. (Pubitemid 29374695)
63. Matsuzwa M, Ota H, Hayama M, et al. Helicobacter pylori infection up-regulates gland mucous cell-type mucins in gastric pyloric mucosa. Helicobacter. 2003;8:594-600. (Pubitemid 37553433)
64. Karasawa F, Shiota A, Goso Y, et al. Essential role of gastric gland mucin in preventing gastric cancer in mice. J Clin Invest. 2012;122:923-934.
65. Talia KL, Scurry J, Manolitsas T, et al. Primary vaginal mucinous adenocarcinoma of gastric type arising in adenosis: a report of 2 cases, 1 associated with uterus didelphys. Int J Gynecol Pathol. 2012;31:184-191.
66. Young RH, Scully RE. Mucinous ovarian tumors associated with mucinous adenocarcinomas of the cervix. A clinicopathological analysis of 16 cases. Int J Gynecol Pathol. 1988;7: 99-111.
67. Seidman JD. Mucinous lesions of the fallopian tube. A report of seven cases. Am J Surg Pathol. 1994;18:1205-1212. (Pubitemid 24362433)
68. Mikami Y, Kiyokawa T, Sasajima Y, et al. Reappraisal of synchronous and multifocal mucinous lesions of the female genital tract: a close association with gastric metaplasia. Histopathology. 2009;54:184-191.
69. Giardiello FM, Trimbath JD. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol. 2006;4:408-415.
70. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447-1453. (Pubitemid 32198669)
71. Omori M, Hashi A, Ishii Y, et al. Clinical impact of preoperative screening for gastric mucin secretion in cervical discharge by HIK1083-labeled latex agglutination test. Am J Clin Pathol. 2008;130:585-594.